These distinct roles of MDA5 and PKR in ADAR1-deficient tumour cells was also reported by another group, where ADAR1 emerged as a candidate from an in vivo CRISPR screen to identify loss of function alleles that confer sensitivity of murine B16 melanoma cells to immune checkpoint blockade [60]. This evidence concerns the gene EIF2AK2 and neoplasm.